Borr Drilling Limited – Results of 2025 Special General Meeting

Borr Drilling Limited (NYSE:BORR) (“BORR” or the “Company”) announces the results of 2025 Special General Meeting (“SGM”), held on August 6, 2025 at 11:00 am (Bermuda local time) at the Company's registered office located at 2nd Floor, The S.E. Pearman Building, 9 Par-la-Ville Road, Hamilton HM 11, Bermuda. At the SGM, the following resolutions were

123Invent Inventor Develops New Formula to Relieve Toothache Pain (CTK-1762)

“I wanted to create an instant way to help relieve pain caused by a toothache,” said an inventor, from Big Spring, Texas, “so I invented INSTANT RELIEF. My formula would suffocate and kill any microbials,bacteria, andgermsin secondstoalleviatepain and freshenthe mouth.” https://mma.prnewswire.com/media/2099578/InventHelp_Logo_jpg_Logo.jpg The invention provides a new formula to help relieve a toothache. In doing so,

2025 Raise Awards Finalists Announced, Honoring Nonprofit Innovation and Impact

INDIANAPOLIS, Aug. 06, 2025 (GLOBE NEWSWIRE) — OneCause, a leading provider of event and online fundraising solutions, announced the finalists for the 2025 Raise Awards. Winners will be recognized at the Raise event fundraising conference, being held September 8-9 in San Antonio, TX. Established to spotlight bold leadership in the sector, the Raise Awards honor

Water Tower Research (WTR) Adds Krista Fitzpatrick as Director – Digital Events & Services

St. Petersburg, FL, Aug. 06, 2025 (GLOBE NEWSWIRE) — Water Tower Research LLC (www.watertowerresearch.com) is modernizing IR with a powerfully differentiated ecosystem of investor relations services, research-driven content and communications, and investor engagement. Water Tower Research is pleased to announce that Krista Fitzpatrick has joined the firm as Director – Digital Events & Services. Shawn

Water Tower Research (WTR) Adds Krista Fitzpatrick as Director – Digital Events & Services

Water Tower Research (WTR) Adds Krista Fitzpatrick as Director – Digital Events & Services Water Tower Research LLC (www.watertowerresearch.com) is modernizing IR with a powerfully differentiated ecosystem of investor relations services, research-driven content and communications, and investor engagement. Water Tower Research is pleased to announce that Krista Fitzpatrick has joined the firm as Director –

2025 Raise Awards Finalists Announced, Honoring Nonprofit Innovation and Impact

2025 Raise Awards Finalists Announced, Honoring Nonprofit Innovation and Impact Nonprofits and Fundraisers Recognized for Bold, Mission-Driven Leadership Ahead of National Conference GlobeNewswire August 06, 2025 INDIANAPOLIS, Aug. 06, 2025 (GLOBE NEWSWIRE) — OneCause, a leading provider of event and online fundraising solutions, announced the finalists for the 2025 Raise Awards. Winners will be recognized

Johnson & Johnson Innovative Medicine’s Tremfya Gains Momentum in Crohn’s Disease, Outpacing Eli Lilly’s Omvoh and Challenging AbbVie’s Skyrizi

EXTON, PA, Aug. 06, 2025 (GLOBE NEWSWIRE) — The Crohn's disease (CD) treatment landscape is undergoing a radical transformation as newer mechanisms of action (MOAs), particularly IL-23 inhibitors and JAK inhibitors, continue displace long-standing therapies like TNF inhibitors. With the recent FDA approvals of Tremfya (guselkumab) and Omvoh (mirikizumab), joining Skyrizi (risankizumab) earlier this year,

Johnson & Johnson Innovative Medicine’s Tremfya Gains Momentum in Crohn’s Disease, Outpacing Eli Lilly’s Omvoh and Challenging AbbVie’s Skyrizi

Johnson & Johnson Innovative Medicine's Tremfya Gains Momentum in Crohn's Disease, Outpacing Eli Lilly's Omvoh and Challenging AbbVie's Skyrizi Strong efficacy and safety perceptions, as well as favorable administration fuel utilization of the IL-23 class in Crohn's disease, according to Spherix Global Insights. GlobeNewswire August 06, 2025 EXTON, PA, Aug. 06, 2025 (GLOBE NEWSWIRE) —

Scroll to Top